vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and INTERFACE INC (TILE). Click either name above to swap in a different company.
INTERFACE INC is the larger business by last-quarter revenue ($349.4M vs $208.9M, roughly 1.7× iRhythm Holdings, Inc.). INTERFACE INC runs the higher net margin — 7.0% vs 2.7%, a 4.3% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 4.3%). INTERFACE INC produced more free cash flow last quarter ($28.6M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 9.8%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
Interface, Inc., headquartered in Atlanta, Georgia, is a global manufacturer of commercial flooring. The company sells modular carpet tiles, luxury vinyl tile, and Nora brand rubber flooring.
IRTC vs TILE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $349.4M |
| Net Profit | $5.6M | $24.4M |
| Gross Margin | 70.9% | 38.6% |
| Operating Margin | 1.1% | 10.1% |
| Net Margin | 2.7% | 7.0% |
| Revenue YoY | 27.1% | 4.3% |
| Net Profit YoY | 518.5% | 12.1% |
| EPS (diluted) | $0.18 | $0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $208.9M | $349.4M | ||
| Q3 25 | $192.9M | $364.5M | ||
| Q2 25 | $186.7M | $375.5M | ||
| Q1 25 | $158.7M | $297.4M | ||
| Q4 24 | $164.3M | $335.0M | ||
| Q3 24 | $147.5M | $344.3M | ||
| Q2 24 | $148.0M | $346.6M | ||
| Q1 24 | $131.9M | $289.7M |
| Q4 25 | $5.6M | $24.4M | ||
| Q3 25 | $-5.2M | $46.1M | ||
| Q2 25 | $-14.2M | $32.6M | ||
| Q1 25 | $-30.7M | $13.0M | ||
| Q4 24 | $-1.3M | $21.8M | ||
| Q3 24 | $-46.2M | $28.4M | ||
| Q2 24 | $-20.1M | $22.6M | ||
| Q1 24 | $-45.7M | $14.2M |
| Q4 25 | 70.9% | 38.6% | ||
| Q3 25 | 71.1% | 39.4% | ||
| Q2 25 | 71.2% | 39.4% | ||
| Q1 25 | 68.8% | 37.3% | ||
| Q4 24 | 70.0% | 36.5% | ||
| Q3 24 | 68.8% | 37.1% | ||
| Q2 24 | 69.9% | 35.4% | ||
| Q1 24 | 66.3% | 38.1% |
| Q4 25 | 1.1% | 10.1% | ||
| Q3 25 | -4.4% | 14.6% | ||
| Q2 25 | -10.0% | 13.9% | ||
| Q1 25 | -20.5% | 7.8% | ||
| Q4 24 | -2.5% | 8.8% | ||
| Q3 24 | -34.1% | 12.3% | ||
| Q2 24 | -15.5% | 11.0% | ||
| Q1 24 | -28.9% | 8.4% |
| Q4 25 | 2.7% | 7.0% | ||
| Q3 25 | -2.7% | 12.7% | ||
| Q2 25 | -7.6% | 8.7% | ||
| Q1 25 | -19.3% | 4.4% | ||
| Q4 24 | -0.8% | 6.5% | ||
| Q3 24 | -31.3% | 8.3% | ||
| Q2 24 | -13.6% | 6.5% | ||
| Q1 24 | -34.6% | 4.9% |
| Q4 25 | $0.18 | $0.41 | ||
| Q3 25 | $-0.16 | $0.78 | ||
| Q2 25 | $-0.44 | $0.55 | ||
| Q1 25 | $-0.97 | $0.22 | ||
| Q4 24 | $-0.03 | $0.38 | ||
| Q3 24 | $-1.48 | $0.48 | ||
| Q2 24 | $-0.65 | $0.38 | ||
| Q1 24 | $-1.47 | $0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | $71.3M |
| Total DebtLower is stronger | — | $181.6M |
| Stockholders' EquityBook value | $152.7M | $640.7M |
| Total Assets | $1.0B | $1.2B |
| Debt / EquityLower = less leverage | — | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $583.8M | $71.3M | ||
| Q3 25 | $565.2M | $187.4M | ||
| Q2 25 | $545.5M | $121.7M | ||
| Q1 25 | $520.6M | $97.8M | ||
| Q4 24 | $535.6M | $99.2M | ||
| Q3 24 | $522.0M | $115.6M | ||
| Q2 24 | $561.5M | $94.2M | ||
| Q1 24 | $569.1M | $89.8M |
| Q4 25 | — | $181.6M | ||
| Q3 25 | — | $307.8M | ||
| Q2 25 | — | $304.4M | ||
| Q1 25 | — | $302.9M | ||
| Q4 24 | — | $302.8M | ||
| Q3 24 | — | $337.9M | ||
| Q2 24 | — | $387.6M | ||
| Q1 24 | — | $391.8M |
| Q4 25 | $152.7M | $640.7M | ||
| Q3 25 | $121.9M | $621.0M | ||
| Q2 25 | $103.7M | $575.0M | ||
| Q1 25 | $86.7M | $513.1M | ||
| Q4 24 | $90.9M | $489.1M | ||
| Q3 24 | $71.8M | $501.6M | ||
| Q2 24 | $99.2M | $451.2M | ||
| Q1 24 | $90.3M | $428.5M |
| Q4 25 | $1.0B | $1.2B | ||
| Q3 25 | $995.2M | $1.3B | ||
| Q2 25 | $964.0M | $1.3B | ||
| Q1 25 | $926.1M | $1.2B | ||
| Q4 24 | $931.4M | $1.2B | ||
| Q3 24 | $909.7M | $1.2B | ||
| Q2 24 | $919.2M | $1.2B | ||
| Q1 24 | $909.8M | $1.2B |
| Q4 25 | — | 0.28× | ||
| Q3 25 | — | 0.50× | ||
| Q2 25 | — | 0.53× | ||
| Q1 25 | — | 0.59× | ||
| Q4 24 | — | 0.62× | ||
| Q3 24 | — | 0.67× | ||
| Q2 24 | — | 0.86× | ||
| Q1 24 | — | 0.91× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $49.3M |
| Free Cash FlowOCF − Capex | $14.5M | $28.6M |
| FCF MarginFCF / Revenue | 6.9% | 8.2% |
| Capex IntensityCapex / Revenue | 5.6% | 5.9% |
| Cash ConversionOCF / Net Profit | 4.70× | 2.02× |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | $121.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.2M | $49.3M | ||
| Q3 25 | $34.9M | $76.7M | ||
| Q2 25 | $27.7M | $30.1M | ||
| Q1 25 | $-7.9M | $11.7M | ||
| Q4 24 | $19.2M | $38.0M | ||
| Q3 24 | $24.3M | $76.2M | ||
| Q2 24 | $11.8M | $21.5M | ||
| Q1 24 | $-52.0M | $12.6M |
| Q4 25 | $14.5M | $28.6M | ||
| Q3 25 | $20.1M | $66.1M | ||
| Q2 25 | $17.3M | $22.8M | ||
| Q1 25 | $-17.3M | $4.3M | ||
| Q4 24 | $12.4M | $24.4M | ||
| Q3 24 | $15.5M | $69.7M | ||
| Q2 24 | $3.4M | $12.0M | ||
| Q1 24 | $-61.8M | $8.6M |
| Q4 25 | 6.9% | 8.2% | ||
| Q3 25 | 10.4% | 18.1% | ||
| Q2 25 | 9.3% | 6.1% | ||
| Q1 25 | -10.9% | 1.4% | ||
| Q4 24 | 7.5% | 7.3% | ||
| Q3 24 | 10.5% | 20.3% | ||
| Q2 24 | 2.3% | 3.5% | ||
| Q1 24 | -46.8% | 3.0% |
| Q4 25 | 5.6% | 5.9% | ||
| Q3 25 | 7.7% | 2.9% | ||
| Q2 25 | 5.6% | 2.0% | ||
| Q1 25 | 5.9% | 2.5% | ||
| Q4 24 | 4.2% | 4.1% | ||
| Q3 24 | 6.0% | 1.9% | ||
| Q2 24 | 5.7% | 2.8% | ||
| Q1 24 | 7.4% | 1.4% |
| Q4 25 | 4.70× | 2.02× | ||
| Q3 25 | — | 1.66× | ||
| Q2 25 | — | 0.93× | ||
| Q1 25 | — | 0.90× | ||
| Q4 24 | — | 1.75× | ||
| Q3 24 | — | 2.68× | ||
| Q2 24 | — | 0.95× | ||
| Q1 24 | — | 0.89× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
TILE
| AMS | $205.9M | 59% |
| EAAA | $143.5M | 41% |
